Lymphoscintigraphic Visualization of Internal Mammary Nodes with Subtumoral Injection of Radiocolloid in Patients with Breast Cancer

Annals of Surgery

Volumn 237, Issue 3, 2003, Pages 390-398

  Shimazu, Kenzo ^a   Tamaki, Yasuhiro ^a   Taguchi, Tetsuya ^a   Motomura, Kazuyoshi ^b   Inaji, Hideo ^b   Koyama, Hiroki ^b   Kasugai, Tsutomu ^b   Wada, Akira ^b   Noguchi, Shinzaburo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Osaka Medical Center for Cancer   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; RADIOISOTOPE; TECHNETIUM 99M; COLORING AGENT; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM DERIVATIVE; TECHNETIUM TC 99M TIN COLLOID; TIN DERIVATIVE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER LOCALIZATION; CANCER STAGING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MASTECTOMY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SENTINEL LYMPH NODE; AXILLA; BIOPSY; BREAST; BREAST TUMOR; COLLOID; INJECTION; LYMPH NODE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AXILLA; BIOPSY; BREAST; BREAST NEOPLASMS; COLLOIDS; COLORING AGENTS; FEMALE; HUMANS; INJECTIONS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, RADICAL; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM COMPOUNDS; TIN COMPOUNDS;

EID: 85047693734     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SLA.0000055226.89022.90     Document Type: Article

References (35)

1. Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer. 1981:47:170-175.
2. Lacour J, Le M, Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten-year results of an international cooperative trial in breast cancer. Cancer. 1983;51:1941-1943.
3. Veronesi U, Marubini E, Mariani L, et al. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer. 1999:35: 1320-1325.
4. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998;186:275-283.
5. Hill AD, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Am Surg. 1999:229:528-535.
6. Johnson N, Soot L, Nelson J, et al. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg. 2000:179: 386-388.
7. Turner-Warwick R. The lymphatics of the breast. Br J Surg. 1959;46: 574-582.
8. Hultborn KA, Larsson LG, Ragnhult I. The lymph drainage from the breast to the axillary and parasternal lymph nodes, studied with the aid of colloidal AU198. Acta Radiol. 1955;43:52-64.
9. Shimazu K, Tamaki Y, Taguchi T, et al. Comparison between periareolar and peritumoral injection of radiotracer for sentinel lymph node biopsy in patients with breast cancer. Surgery. 2002;131:277-286.
10. Haagensen CD. Anatomy of the mammary glands. In: Disease of the breast. Philadelphia: WB Saunders: 1986:1-46.
11. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med. 1998;339:941-946.
12. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645-653.
13. Linehan DC, Hill AD, Akhurst T, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol. 1999;6:450-454.
14. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864-1867.
15. Klimberg VS, Rubio IT, Henry R, et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg. 1999;229: 860-865.
16. Jansen L, Doting MH, Rutgers EJ, et al. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg. 2000;87:920-925.
17. Martin RC, Derossis AM, Fey J, et al. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery. 2001;130:432-438.
18. Borgstein PJ, Meijer S, Pijpers RJ, et al. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. Ann Surg. 2000;232:81-89.
19. Uren RF, Howman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med. 1995;36:1775-1780.
20. Roumen RM, Geuskens LM, Valkenburg JG. In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol. 1999;25:347-351.
21. van der Ent FW, Kengen RA, van der Pol HA, et al. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg. 2001;234:79-84.
22. Birdwell RL, Smith KL, Betts BJ, et al. Breast cancer: variables affecting sentinel lymph node visualization at preoperative lymphoscintigraphy. Radiology. 2001;220:47-53.
23. Byrd DR, Dunnwald LK, Mankoff DA, et al. Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol. 2001;8:234-240.
24. Paganelli G, Cicco CD. Sentinel node biopsy. Reply to Bourgeois et al. Eur J Nucl Med. 1998:25:1589-1590.
25. Cserni G, Pap Szekeres J. Internal mammary lymph nodes and sentinel node biopsy in breast cancer. Surg Oncol. 2001;10:25-33.
26. McMasters KM, Giuliano AE, Ross MI, et al. Sentinel-lymph-node biopsy for breast cancer - not yet the standard of care. N Engl J Med. 1998;339:990-995.
27. Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg. 2001:233:51-59.
28. McMasters KM, Wong SL, Martin RC 2nd, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg. 2001;233:676-687.
29. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368-373.
30. Halsell JT, Smith JR, Bentlage CR, et al. Lymphatic drainage of the breast demonstrated by vital dye staining and radiography. Ann Surg. 1965;162:221-226.
31. Gulec SA, Moffat FL, Carroll RG, et al. Gamma probe guided sentinel node biopsy in breast cancer. Q J Nucl Med. 1997:41:251-261.
32. Klauber-DeMore N, Bevilacqua JL, Van Zee KJ, et al. Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg. 2001;193:547-555.
33. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;15;353:1641-1648.
34. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949-955.
35. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956-962.